Accession Number: | 0001237899-20-000029 |
Date: | 2020-07-07 |
Issuer: | REGENERON PHARMACEUTICALS, INC. (REGN) |
Original Submission Date: |
SING GEORGE L
777 OLD SAW MILL RIVER ROAD
TARRYTOWN, NY 10591
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-07-07 | M | 7,500 | a | $33.42 | 122,915 | direct | ||
COMMON STOCK | 2020-07-07 | S | 7,500 | d | $650.00 | 115,415 | direct | ||
COMMON STOCK | 2020-07-07 | S | 500 | d | $650.00 | 1,150 | indirect | ||
COMMON STOCK | 2020-07-07 | S | 800 | d | $650.32 | 600 | indirect | ||
COMMON STOCK | 2020-07-07 | S | 200 | d | $651.09 | 400 | indirect | ||
COMMON STOCK | 2020-07-07 | S | 1,500 | d | $650.00 | 4,700 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) | 33.42 | 2020-07-07 | deemed execution date | M | 7,500 (d) | 2021-01-03 | common stock 7,500 | $33.42 | 0 | direct |
ID | footnote |
---|---|
f1 | disposition/acquisition made pursuant to a plan intended to comply with rule 10b5-1(c). |
f2 | represents volume-weighted average price of sales of 800 shares of company stock on july 7, 2020 at prices ranging from $650.00 to $650.83. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on july 7, 2020 at each separate price. |
f3 | represents volume-weighted average price of sales of 200 shares of company stock on july 7, 2020 at prices ranging from $651.02 to $651.10. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on july 7, 2020 at each separate price. |
f4 | the stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant. |